Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide

L Ferrer-Font, N Arias-Ramos, S Lope-Piedrafita, M Julià-Sapé, M Pumarola, C Arús, AP Candiota

Research output: Contribution to journalArticleResearch

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)-
JournalNMR in Biomedicine, doi: 10.1002/nbm.3748
Publication statusPublished - 1 Jan 2017

Cite this